Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yellow fever vaccine immunity in immunosuppressed rheumatoid arthritis patients
RBR-946bv5Completed
- Sponsor
- Instituto René Rachou
- Start
- Sep 2014
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of 17D yellow fever vaccine in yellow fever (2 cohorts), sponsored by Instituto René Rachou. Primary endpoints: Neutralizing antibody levels and Cellular immunity analysis. Started Sep 2014; status: completed.
02
Drugs
17D yellow fever vaccine
03
Conditions
yellow fever
Beyond the preview
Go deeper on RBR-946bv5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-946bv5.